Ethimed

Ethimedix is a Swiss biopharmaceutical company focused on developing innovative solutions for pain management through the integration of drug delivery and digital health technologies. The company's lead product, SOPROFEN, is a digital patient-controlled analgesia (PCA) system designed to deliver sufentanil, a potent opioid, in a controlled and secure manner to manage post-operative pain. By utilizing a proprietary digital platform, Ethimedix aims to improve patient safety, reduce the risk of opioid misuse, and optimize analgesic efficacy in clinical settings. The company is currently advancing its clinical programs to bring this next-generation pain management system to the global market.